NCT02295176View on ClinicalTrials.gov

Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

July 31, 2015

Conditions
Metabolic SyndromeInsulin-resistanceLeft Ventricular Hypertrophy
Interventions
DIETARY_SUPPLEMENT

Armolipid Plus

DIETARY_SUPPLEMENT

Placebo

Trial Locations (3)

80131

Domenico Bonaduce, Naples

Unknown

Ferruccio Galletti, Naples

Giuseppe Schillaci, Terni

All Listed Sponsors
lead

Rottapharm

INDUSTRY

NCT02295176 - Metabolic and Cardiovascular Effects of Armolipid Plus in Subjects With Metabolic Syndrome | Biotech Hunter | Biotech Hunter